haleon plc glp-1 receptor agonist medications Advil Maker's CEO Aims to Play in Weight-Loss Market From Sidelines Oral GLP-1 Orforglipron Is Approved

Front Psychol

Ultimately, success with these medications isnt about taking a magic pillits about addressing the root causes of weight gain, and creating sustainable habits that honor both your physical and mental health

Expert Opin Drug Metab Toxicol

Before matching, patients in the trial eligible and expanded populations initiating semaglutide or tirzepatide were younger, more likely to be white and were more frequently prescribed sulfonylureas compared to sitagliptin or dulaglutide users

The differences in cardiovascular outcomes observed between trials of GLP-1 receptor agonists may relate to variations in the design and populations of the trials, but could also be the result of the different characteristics of the GLP-1 receptor agonists themselves (39,40)

Swenne, I